A subchorionic hematoma (SCH) is a blood clot that forms between the outer membrane of the pregnancy sac (the chorion) and the uterine wall. It is one of the most common findings on early pregnancy ultrasound, and it is also one of the most anxiety-inducing. The research picture is genuinely mixed: some studies link SCH to higher rates of miscarriage and other complications, while others find that most pregnancies with SCH proceed normally. What matters most is the size of the clot relative to the pregnancy sac, whether it causes bleeding, and how long it sticks around.
What a Subchorionic Hematoma Actually Is
During early pregnancy, the developing placenta embeds into the uterine lining. A subchorionic hematoma forms when blood collects in the space where the chorion has partially separated from the decidua, the specialized lining of the uterus during pregnancy. On ultrasound, it shows up as a dark, crescent-shaped or irregular pocket of fluid next to or beneath the gestational sac. Some women discover they have one only because they experience vaginal bleeding or spotting; others find out incidentally during a routine scan, with no symptoms at all.
It is worth distinguishing SCH from a retroplacental hematoma, which sits behind the placenta rather than along the edge of the pregnancy sac. One study found that all subchorionic hematomas eventually resolved, while a small fraction of retroplacental hematomas persisted into the second trimester, and the miscarriage rate with retroplacental hematomas was significantly higher.1PubMed Central. The Impact of Incidental Ultrasound Finding of Subchorionic and Retroplacental Hematoma in Early Pregnancy The location of the clot matters, and your ultrasound report should specify which type you have.
Why They Form
The honest answer is that researchers do not fully understand why some women develop SCH and others don’t. A 2024 review noted that the exact cause remains unclear, though current evidence points to a mix of possible contributors: abnormal blood clotting, autoimmune factors, use of certain medications during pregnancy, reproductive tract infections, and assisted reproduction.2PubMed Central. Subchorionic hematoma: Research status and pathogenesis
On the clotting side, specific lab findings have been tied to SCH risk. A study analyzing blood markers in pregnant women with SCH found that decreased protein S activity and antithrombin-III levels, elevated homocysteine, and the presence of certain autoantibodies (like lupus anticoagulant and anticardiolipin antibody) were all risk factors.3PubMed Central. Analysis of risk factors and pregnancy outcomes in pregnant women with subchorionic hematoma In plain terms, these are markers of a blood-clotting system that isn’t working quite right, or an immune system that is producing antibodies against normal pregnancy tissues.
SCH After IVF and Fertility Treatment
If you conceived through IVF, your odds of developing an SCH are roughly double those of someone who conceived naturally. One study found SCH in about 22% of IVF pregnancies compared with 11% of non-IVF pregnancies.4PubMed. Subchorionic hematoma occurs more frequently in in vitro fertilization pregnancy A more detailed breakdown showed that fresh embryo transfers had the highest rate (about 28%), followed by frozen embryo transfers (about 23%), while natural pregnancies and artificial insemination both came in around 13%.5PubMed Central. Incidence of subchorionic hematoma and contributing factors in assisted reproductive technologies—a retrospective cohort study
The reasons likely involve the hormonal environment that IVF creates. High estrogen and progesterone levels during fresh embryo transfer cycles, polycystic ovary syndrome, tubal fluid buildup, and even low-dose aspirin use during pregnancy were all found to increase SCH risk in IVF patients.6PubMed. Risk Factors of Subchorionic Hematoma Under Assisted Reproductive Technology Interestingly, embryo quality also played a role: lower-quality embryos were associated with higher SCH rates.7PubMed Central. Incidence of subchorionic hematoma and contributing factors in assisted reproductive technologies—a retrospective cohort study If you’re going through IVF and hear you have an SCH, know that it’s considerably more common in your situation than in the general pregnant population and doesn’t automatically signal something has gone wrong with the pregnancy itself.
Does Size Matter?
This is probably the most important practical question, and the answer is yes, with some caveats about how “size” is measured. Not all grading systems work equally well. One study tested four different methods of sizing hematomas and found that estimating the hematoma as a fraction of the gestational sac size was the approach that significantly predicted first-trimester pregnancy loss. The other subjective grading methods did not reach significance, and volume-based measurements were unreliable because most hematomas have irregular shapes.8PubMed. Subchorionic Hematoma: Correlation of Grading Techniques With First-Trimester Pregnancy Outcome
A classic study from the radiology literature grouped hematomas into small, moderate, and large categories and found that the miscarriage rate nearly doubled with large separations (about 19%) compared with small and moderate ones (about 8% and 9% respectively). A large separation carried close to three times the risk of spontaneous abortion.9PubMed. Subchorionic hemorrhage in first-trimester pregnancies: prediction of pregnancy outcome with sonography
The evidence gets more dramatic when you look at the extremes. A Polish study grouped hematomas into three size categories (I, II, and III, from smallest to largest). The largest category (SCH III) had strikingly worse outcomes across the board: early pregnancy loss occurred in about 43% of the SCH III group versus roughly 9% in the smallest-hematoma group and 3% in women without any hematoma. Preterm delivery hit about 43% in the SCH III group versus 9% in the smallest group. Fetal growth restriction affected about 24% of the SCH III group compared with 2% of the smallest group.10PubMed Central. How does subchorionic hematoma in the first trimester affect pregnancy outcomes?
However, at least one study found a different picture. Research on singleton pregnancies found that the size of the SCH was not related to pregnancy loss before 20 weeks.11Scientific Reports. Association between first-trimester subchorionic hematoma and pregnancy loss before 20 weeks of gestation in singleton pregnancies The conflicting evidence likely reflects differences in how hematomas were measured and how large “large” was defined. The overall trend in the literature is that bigger hematomas relative to the gestational sac carry more risk, but a small SCH found incidentally is rarely cause for alarm.
Miscarriage Risk in Context
The headline fear with any SCH is miscarriage, and the numbers do show an elevated risk, but the absolute numbers matter more than the relative ones. In a study of women who already had vaginal bleeding (threatened abortion), about 30% of those with an SCH on ultrasound miscarried, compared with about 13% of those without one.12PubMed Central. The effects of subchorionic hematoma on pregnancy outcome in patients with threatened abortion That is a meaningful difference, but notice it also means roughly 70% of pregnancies with SCH and active bleeding still continued. The same study found that for pregnancies that did continue, the SCH did not affect other outcome measures, which is genuinely reassuring.13PubMed Central. The effects of subchorionic hematoma on pregnancy outcome in patients with threatened abortion
Keep in mind that the 30% figure came from women who were already bleeding. For women whose SCH is found incidentally on ultrasound with no symptoms, the miscarriage rate is lower. The size of the hematoma is the critical variable. If you have a small SCH, no bleeding, and a normally growing embryo with a heartbeat, the odds are strongly in your favor.
Beyond Miscarriage: Later Pregnancy Complications
Even when the pregnancy continues past the first trimester, an SCH can leave a fingerprint on later outcomes. One finding that comes up repeatedly is fetal growth restriction (FGR), where the baby grows more slowly than expected. A study of singleton pregnancies found that first-trimester SCH was independently associated with about four times the odds of FGR, after adjusting for vaginal bleeding.14PubMed Central. A nomogram for predicting the risk of fetal growth restriction in singleton pregnancies with subchorionic hematomas detected in first trimester The absolute rate was still low (4% in the SCH group versus about 1% without SCH), but the relative increase was notable.
How long the hematoma persists also matters. Research on asymptomatic SCH found that the duration of the hematoma was linked to higher rates of fetal growth restriction, gestational diabetes, and premature rupture of membranes at term. Larger hematomas were also associated with complications like gestational hypothyroidism, pregnancy-related high blood pressure, low platelet counts, and abnormal placental attachment.15PubMed Central. Associations between the size and duration of asymptomatic subchorionic hematoma and pregnancy outcomes in women with singleton pregnancies The theme across these studies is that larger and longer-lasting hematomas tend to signal more disruption to normal placental development.
A large retrospective study of over 1,100 women with SCH who reached the third trimester found that about 72% were diagnosed with at least one pregnancy complication. Premature birth occurred in about 9% of cases, and low birth weight in about 6%.16PubMed Central. Subchorionic Hematoma Association with Pregnancy Complications and Outcomes in the Third Trimester – Section: Results These rates are higher than in the general population, though this particular study did not have a matched control group, so the numbers reflect the SCH population rather than a clean comparison.
SCH in Twin Pregnancies
The dynamics change somewhat with twins. One study of twin pregnancies found that SCH by itself was not associated with adverse outcomes regardless of size, with one exception: an increased need for blood transfusion at delivery. But when the SCH also came with vaginal bleeding, there was an increased risk of preterm birth.17American Journal of Obstetrics & Gynecology. Subchorionic hematomas and adverse pregnancy outcomes among twin pregnancies
Another twin study painted a more concerning picture for early pregnancy, finding that first-trimester hematomas were associated with dramatically increased odds of miscarriage and vanishing twin syndrome (where one twin stops developing). However, for twin pregnancies that continued, there were no significant differences in rates of stillbirth, preeclampsia, preterm labor before 34 weeks, low birth weight, or fetal distress.18PubMed Central. Associations between first-trimester intrauterine hematoma and twin pregnancy outcomes: a retrospective cohort study In other words, the main risk in twin pregnancies with SCH seems to be early loss; once past that hurdle, the outlook improves.
Treatment Options and Their Limits
This is where the evidence is thin and, frankly, frustrating. There is no proven treatment that makes a subchorionic hematoma resolve faster or reliably prevents complications. The two interventions most commonly discussed are bed rest and progesterone supplementation, and neither has strong evidence behind it.
One older study found that women with SCH who adhered to bed rest had fewer miscarriages (about 10% versus 23%) and a higher rate of reaching term (89% versus 70%) compared with those who didn’t rest.19PubMed. Pregnancy outcome of threatened abortion with subchorionic hematoma: possible benefit of bed-rest? That sounds promising, but the study wasn’t randomized, meaning women who chose bed rest may have differed from those who didn’t in ways that affected the outcome. A trial comparing dydrogesterone (a type of progesterone) plus bed rest versus bed rest alone found no significant difference in hematoma resolution or miscarriage rates after two weeks of treatment.20Philippine Journal of Obstetrics and Gynecology. Dydrogesterone and bed rest vs. bed rest alone in the management of hemorrhage
A separate study reported only a 7% miscarriage rate in 100 women treated with oral dydrogesterone, which was lower than the 19% rate seen in a prior study using a different form of progesterone.21PubMed. Subchorionic hemorrhage treatment with dydrogesterone But without a placebo control group, it’s impossible to know how many of those women would have done fine without any treatment. Some SCH cases prove resistant to treatment entirely: a case report described multiple hematomas that did not respond to either progesterone or tranexamic acid (a clot-stabilizing drug).22PubMed Central. A Case of Large Subchorionic Hematoma
In practice, many providers will suggest reduced activity and pelvic rest (avoiding intercourse and heavy lifting), and some will prescribe progesterone, especially if there is active bleeding. These are low-risk interventions, but you should know that the evidence supporting them is weak. The most important thing your provider can do is monitor the hematoma with follow-up ultrasounds to track whether it’s growing, stable, or shrinking.
What Blood Tests Can and Cannot Tell You
Researchers have been looking for blood markers that might predict which SCH pregnancies will end well and which won’t. A machine learning study found that among the most influential predictors of delivery outcome in SCH pregnancies were the initial HCG level, how long the hematoma lasted, CA-125 levels, gestational sac size, and fibrinogen levels.23Medical Science Monitor. Evaluation of Pregnancy Risks in Women with Subchorionic Hematoma Using Machine Learning Models In other words, a combination of how well the pregnancy is progressing hormonally and how the clotting system is functioning seems to carry the most predictive weight.
Women with threatened abortion and SCH tend to have lower progesterone, estrogen, and HCG levels, alongside higher CA-125 and shifts in immune system markers toward an inflammatory profile.24Tobacco Regulatory Science. Predictive Values of Serum Progesterone, Human Chorionic Gonadotropin and CA-125 for Pregnancy Outcomes of Threatened Abortion and Subchorionic Hematoma None of these markers alone is a reliable crystal ball, but low HCG that isn’t rising appropriately combined with a large or growing SCH is a combination that warrants closer monitoring.
How SCH Can Affect Prenatal Screening Results
One thing that rarely gets mentioned but can cause real confusion is that an SCH can interfere with routine prenatal blood screening. A study found that women with SCH had higher maternal serum alpha-fetoprotein (MSAFP) levels than women without SCH. There was a small but statistically significant correlation between AFP levels and hematoma size.25Annals of Clinical and Analytical Medicine. Impact of subchorionic hematoma on maternal serum alpha-fetoproteinlevels and second trimester screening outcomes in threatened abortion cases AFP is one of the markers used in second-trimester screening for neural tube defects and chromosomal abnormalities. A falsely elevated result could trigger unnecessary anxiety, additional testing, or even an amniocentesis that wouldn’t have been recommended otherwise.
The good news is that while MSAFP levels were statistically higher in the SCH group, the sensitivity and specificity of SCH as a predictor of abnormal AFP were both low. There was no significant difference in actual neural tube defect risk between the groups.26Annals of Clinical and Analytical Medicine. Impact of subchorionic hematoma on maternal serum alpha-fetoproteinlevels and second trimester screening outcomes in threatened abortion cases If you have or had an SCH and your second-trimester screening comes back with a mildly elevated AFP, it’s worth mentioning the hematoma history to your provider. The elevation may be from the clot rather than from a fetal problem.
When Hematomas Persist
Most subchorionic hematomas resolve on their own during the first trimester or early second trimester. The ones that don’t resolve quickly deserve more attention. Research on asymptomatic SCH found that the longer a hematoma lasted, the more strongly it was associated with complications including gestational diabetes, premature rupture of membranes, and fetal growth restriction.27PubMed Central. Associations between the size and duration of asymptomatic subchorionic hematoma and pregnancy outcomes in women with singleton pregnancies A persistent hematoma likely indicates ongoing disruption at the placenta-uterine interface, and that disruption can affect how well nutrients and oxygen are delivered to the developing baby over the course of the pregnancy.
If your SCH hasn’t resolved by the end of the first trimester, your provider will probably want serial ultrasounds to monitor both the hematoma and fetal growth. A growing or stable hematoma past the first trimester is a different clinical situation from a small clot that’s already shrinking at eight or nine weeks. The trajectory matters as much as the initial finding.
The Emotional Weight of an SCH Diagnosis
Something that clinical studies rarely capture is how terrifying it is to bleed during pregnancy, and then to be told there’s a blood clot between your baby and your uterine wall. The standard medical advice in many cases amounts to “wait and see,” which is exactly the thing that is hardest to do. Making this worse is that SCH is common enough that most OBs encounter it routinely, yet uncommon enough that many pregnant women have never heard of it until it happens to them. That disconnect between how casually it’s discussed in the exam room and how alarming it feels at home is a real source of distress.
What can actually help is understanding the numbers. Even in studies that show increased risk, most pregnancies with SCH result in a healthy delivery. The absolute risk of miscarriage in the presence of a small, incidental SCH is far lower than what you’ll find if you start searching the internet at 2 a.m. And for pregnancies that continue past the first trimester, the downstream risks (growth restriction, preterm birth) are elevated but still not the norm. Staying in touch with your provider, getting scheduled follow-up imaging, and knowing which symptoms to call about (heavy bleeding, severe cramping, dizziness) are more productive than bed rest and worry.